Skip to content

MeiraGTx Holdings plc MGTX Equity Method Investments

Equity Method Investments at other companies

Opko Health logo
Opko HealthOPK
$10.53M-17.4%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$81.94M-24.9%

Other financials

Income statement

See full
Revenue$293.0K-84.8%
Operating income-$40.8M+1.9%
Net income-$46.3M-15.8%
EPS (diluted)-$0.57-11.8%

Balance sheet

See full
Cash & equivalents$71.5M+7.5%
Total debt$62.7M-22.5%
Total equity-$58.1M-276%
Total assets$244.7M+9.2%

Cash flow

See full
Operating cash flow$17.8M+148%
CapEx$2.0M+17.4%
Free cash flow$15.8M+141%

Valuation

See full
Market cap$1.07B+111%
Enterprise value$1.07B+103%
P/S13.5×-1.3×

Profitability

See full
Operating margin-597.9%-207pp
Net margin-615.3%
FCF margin-441.5%-126pp

Returns & leverage

See full
Return on equity-379.5%
Debt / equity27.2×+26.1×
Current ratio0.5×-1.0×

Where this comes from

Reported directly by MeiraGTx Holdings plc in its filing.

Tagged under the XBRL concept us-gaap:EquityMethodInvestments.

The official record: MeiraGTx Holdings plc’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MeiraGTx Holdings plc's equity method investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MeiraGTx Holdings plc's equity method investments?
MeiraGTx Holdings plc (MGTX) reported equity method investments of $6.75M in Q1 2026.
How has MeiraGTx Holdings plc's equity method investments changed year-over-year?
MeiraGTx Holdings plc's equity method investments decreased by 0.0% year-over-year, from $6.75M to $6.75M.
What is the long-term trend for MeiraGTx Holdings plc's equity method investments?
Over 4 years (2021 to 2025), MeiraGTx Holdings plc's equity method investments has grown at a 0.3% compound annual growth rate (CAGR), from $6.66M to $6.75M.
What does equity method investments mean?
Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.